Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
283 Leser
Artikel bewerten:
(0)

iPad Altering Interaction between Pharma Sales Forces, Physicians, & Consumers

CHAPEL HILL, N.C., Feb. 1, 2013 /PRNewswire/ --The integration of the iPad into the pharmaceutical industry has had a substantial impact on the sector's interactions with physicians and payers. The growth of tablet technology is rapidly transforming how field sales forces in the pharmaceutical industry communicate with physicians and payers.

While the implementation of the iPad has been rapid and exponential, effectively integrating iPads into the field requires significant planning and training to make the investment a success. A new benchmark study completed by research and consulting firm Best Practices, LLC uncovered strategies for measuring the effectiveness of the iPad as an inventive sales tool.

The report, Deploying the iPad to Sales & Managed Markets Teams: Training and Effectiveness Benchmark, focuses onkey challenges and best practiceswhen deploying iPads or Android-Based tablets to large customer-facing commercial groups within pharmaceutical and medical device organizations.

Among the findings that Best Practices uncovered:

  • Approximately one in five companies have already issued iPads to their managed markets teams, with an overall majority of benchmark companies planning to do so in the next 12 months.

The 66-page report contains over 130 metrics and 41 narratives to provide biopharmaceutical leaders with an evidence-based understanding of how other companies in the pharmaceutical and medical device industries are attempting to align their resources and activities to ensure the continuity of their sales' processes.

Key Topics of this report include:

  • Training
  • Systems Integration and Application Development
  • Security and Compliance
  • Applications that Increase Productivity
  • Field Usage and Measuring Effectiveness
  • Challenges and Best Practices in Making the Investment a Success

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1168.htm.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.